已收盤 05-08 16:00:00 美东时间
-1.310
-2.87%
Oppenheimer analyst Suraj Kalia maintains Inspire Medical Systems (NYSE:INSP) from Perform to Perform.
05-07 23:07
今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元
05-06 11:29
The Nasdaq 100 surged past 28,000 during Tuesday morning trading, setting a fresh record as AI-driven gains in semiconductor stocks continued to power the broader tech sector, defying pressure from elevated oil prices and geopolitical tension.
05-06 01:33
斯特林建筑涨22.65%;Pinterest涨15.11%;Firefly Aerospace涨7.43%
05-05 15:01
斯特林建筑涨23.23%;Pinterest涨15.11%;Penguin Solutions Incorporation涨7.16%
05-05 13:01
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Inspire Medical Systems 2026年第一季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** 第一季度营收2.046亿美元,同比增长1.6%,主要由市场渗透率提升驱动。但受编码、报销不确定性及WISER项目影响,营收损失约2000万美元。 **盈利能力:** 运营利润率和调整后运营利润率均有改善,主要得益于Inspire V系统销售占比提高带来的毛利率扩张。 **每股收益:** 报告期稀释每股收益为亏损0.39美元,调整后稀释每股收益为0.10美元。 **现金流状况:** 运营现金流为1280万
05-05 12:28
华盛资讯5月5日讯,Inspire Medical系统公布2026财年Q1业绩,公司Q1营收2.05亿美元,同比增长1.6%,归母净利润亏损0.11亿美元,由盈转亏。
05-05 05:06
Inspire Medical Systems shares are trading lower after the company reported Q1 ...
05-05 04:48
华盛资讯5月5日讯,Inspire Medical系统公布2026财年Q1业绩,公司Q1营收2.05亿美元,同比增长1.6%,归母净利润亏损0.11亿美元,由盈转亏。
05-05 04:36
Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.28) by 135.71 percent. This is unchanged from the same period last year. The company
05-05 04:04